Search Keyword:


Search option:


IID00945
UniprotP51532
ProteinTranscription activator BRG1
GeneSMARCA4
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
1647
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 172-213 Hetero octamer : Q15532
 Evidence X-RAY 7vrb A Reference
       Region 7vrb A 172-208 order
       Region 7vrb A 209-213 disorder
 Evidence X-RAY 7vrb B Reference
       Region 7vrb B 172-207 order
       Region 7vrb B 208-213 disorder
 Evidence X-RAY 7vrb C Reference
       Region 7vrb C 172-207 order
       Region 7vrb C 208-213 disorder
 Evidence X-RAY 7vrb D Reference
       Region 7vrb D 172-207 order
       Region 7vrb D 208-213 disorder
Seq 610-658 Monomer :
 Evidence NMR 6sy2 A Reference
       Region 6sy2 A 610-658 order
       Region 6sy2 A 610-610 high_rmsd
       Region 6sy2 A 655-658 high_rmsd
Seq 874-878 Hetero dimer : Q8N1T3
 Evidence NMR 8eb1 A Reference
       Region 8eb1 A 874-878 order
       Region 8eb1 A 874-878 high_rmsd
Seq 1447-1569 Hetero tetramer : IID00371Complex
 Evidence X-RAY 8g1q H Reference
       Region 8g1q H 1447-1454 disorder
       Region 8g1q H 1455-1569 order
Seq 1448-1580 Monomer :
 Evidence X-RAY 5dkd A Reference
       Region 5dkd A 1451-1456 disorder
       Region 5dkd A 1457-1566 order
       Region 5dkd A 1567-1569 disorder
 Evidence X-RAY 5dkd B Reference
       Region 5dkd B 1451-1456 disorder
       Region 5dkd B 1457-1566 order
       Region 5dkd B 1567-1569 disorder
 Evidence X-RAY 5ea1 A Reference
       Region 5ea1 A 1451-1451 disorder
       Region 5ea1 A 1452-1565 order
       Region 5ea1 A 1566-1580 disorder
 Evidence X-RAY 5ea1 B Reference
       Region 5ea1 B 1451-1578 order
       Region 5ea1 B 1579-1580 disorder
 Evidence X-RAY 5ea1 C Reference
       Region 5ea1 C 1451-1569 order
       Region 5ea1 C 1570-1580 disorder
 Evidence X-RAY 2grc A Reference
       Region 2grc A 1448-1448 disorder
       Region 2grc A 1449-1569 order
       Region 2grc A 1570-1575 disorder
 Evidence X-RAY 3uvd A Reference
       Region 3uvd A 1448-1568 order
       Region 3uvd A 1569-1569 disorder
 Evidence NMR 2h60 A Reference
       Region 2h60 A 1452-1460 disorder
       Region 2h60 A 1461-1565 order
       Region 2h60 A 1566-1570 disorder
 Evidence X-RAY 7tab A Reference
       Region 7tab A 1448-1570 order
       Region 7tab A 1571-1575 disorder
Seq 1449-1568 Hetero octamer : IID00371Complex
 Evidence X-RAY 6hr2 A Reference
       Region 6hr2 A 1449-1451 disorder
       Region 6hr2 A 1452-1568 order
 Evidence X-RAY 6hr2 E Reference
       Region 6hr2 E 1449-1568 order
Seq 1451-1569 Homo dimer :
 Evidence X-RAY 6zs2 A Reference
       Region 6zs2 A 1451-1569 order
 Evidence X-RAY 6zs2 B Reference
       Region 6zs2 B 1451-1569 order
Seq 1591-1602 Hetero dimer : IID00979Complex
 Evidence NMR 6bgh B Reference
       Region 6bgh B 1591-1602 order
SeqProS predicted 1591-1602 This region is predicted to be disordered by AlphaFold (pLDDT <68.5) and NeProc. Hetero dimer : IID00979Complex
       Region 6bgh B 1591-1602 order
Seqphosphorylation
    1631-1631 Phosphoserine
    1627-1627 Phosphoserine
    1586-1586 Phosphoserine
    1575-1575 Phosphoserine
    1570-1570 Phosphoserine
    1452-1452 Phosphoserine
    1423-1423 Phosphothreonine
    1382-1382 Phosphoserine
    699-699 Phosphoserine
    695-695 Phosphoserine
    613-613 Phosphoserine
    610-610 Phosphoserine
    609-609 Phosphothreonine
    353-353 Phosphothreonine
    11-11 Phosphothreonine
Seqacetylation
    626-626 N6-acetyllysine
    188-188 N6-acetyllysine
 
Prediction
NeProc
Disorder 1-350,462-473,493-507,553-560,596-615,634-636,642-723,1028-1031,1253-1334,1340-1389,1418-1455,1568-1647
Order 351-461,474-492,508-552,561-595,616-633,637-641,724-1027,1032-1252,1335-1339,1390-1417,1456-1567
ProS 178-207,301-305,325-329,347-350,462-473,493-507,553-560,596-615,634-636,642-660,689-693,702-712,720-723,1276-1334,1340-1356,1367-1389,1418-1419,1622-1629
AlphaFold
Disorder 1-172,193-193,206-360,429-446,520-520,522-565,567-568,571-571,575-575,579-579,582-614,653-731,915-915,931-931,942-942,945-960,985-987,1014-1036,1066-1067,1159-1162,1232-1240,1254-1295,1349-1451,1568-1647
Order 173-192,194-205,361-428,447-519,521-521,566-566,569-570,572-574,576-578,580-581,615-652,732-914,916-930,932-941,943-944,961-984,988-1013,1037-1065,1068-1158,1163-1231,1241-1253,1296-1348,1452-1567
Pfam Hmmer
612->656 460-532 757->1052
SEG 6-55 ,130-159 ,221-247 ,252-289 ,304-330 ,407-418 ,454-474 ,572-593 ,657-672 ,691-702 ,1019-1034 ,1283-1300 ,1313-1327 ,1353-1364 ,1393-1403 ,1407-1418 ,1421-1443 ,1567-1590 ,1611-1621 ,1627-1647
Function
Function in SwissProt
Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating the calcium-dependent release of a repressor complex and the recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by SMARCA4-dependent recruitment of a phospho-RB1-HDAC repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves the release of HDAC1 and recruitment of CREBBP. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development, a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth. SMARCA4/BAF190A may promote neural stem cell self-renewal/proliferation by enhancing Notch-dependent proliferative signals, while concurrently making the neural stem cell insensitive to SHH-dependent differentiating cues (By similarity). Acts as a corepressor of ZEB1 to regulate E-cadherin transcription and is required for induction of epithelial-mesenchymal transition (EMT) by ZEB1. Binds via DLX1 to enhancers located in the intergenic region between DLX5 and DLX6 and this binding is stabilized by the long non-coding RNA (lncRNA) Evf2 (By similarity). Binds to RNA in a promiscuous manner (By similarity). Binding to RNAs including lncRNA Evf2 leads to inhibition of SMARCA4 ATPase and chromatin remodeling activities (By similarity). In brown adipose tissue, involved in the regulation of thermogenic genes expression (By similarity).
Biological Process
See also
Diagram with PDB data
REST/Sin3bSolution structure of the NRSF/REST-mSin3B PAH1 complex